Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Opthea Exploring Different Approach To Treating Wet AMD

    Opthea Exploring Different Approach To Treating Wet AMD

    FromOIS Podcast | Ophthalmology's leading Podcast

    Start listeningView podcast show

    Opthea Exploring Different Approach To Treating Wet AMD

    FromOIS Podcast | Ophthalmology's leading Podcast

    ratings:
    Length:
    20 minutes
    Released:
    Aug 31, 2015
    Format:
    Podcast episode

    Description

    Australia-based Opthea is moving forward with clinical trials in the US, testing its OPT-302 compound along and in combination with Lucentis as a potential treatment for Wet AMD. CEO Megan Baldwin explains the company’s approach up until now and its plans going forward.
    Released:
    Aug 31, 2015
    Format:
    Podcast episode

    Titles in the series (100)

    Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.